Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity.
Talianová V, Kejík Z, Kaplánek R, Veselá K, Abramenko N, Lacina L, Strnadová K, Dvořánková B, Martásek P, Masařík M, Megová MH, Bušek P, Křížová J, Zdražilová L, Hansíková H, Vlčák E, Filimonenko V, Šedo A, Smetana K Jr, Jakubek M. Talianová V, et al. Among authors: masarik m. Pharmaceutics. 2022 Aug 17;14(8):1712. doi: 10.3390/pharmaceutics14081712. Pharmaceutics. 2022. PMID: 36015338 Free PMC article.
Role of mtDNA disturbances in the pathogenesis of Alzheimer's and Parkinson's disease.
Antonyová V, Kejík Z, Brogyányi T, Kaplánek R, Pajková M, Talianová V, Hromádka R, Masařík M, Sýkora D, Mikšátková L, Martásek P, Jakubek M. Antonyová V, et al. Among authors: masarik m. DNA Repair (Amst). 2020 Jul-Aug;91-92:102871. doi: 10.1016/j.dnarep.2020.102871. Epub 2020 May 21. DNA Repair (Amst). 2020. PMID: 32502755 Review.
Novel Mitochondria-targeted Drugs for Cancer Therapy.
Fialova JL, Raudenska M, Jakubek M, Kejik Z, Martasek P, Babula P, Matkowski A, Filipensky P, Masarik M. Fialova JL, et al. Among authors: masarik m. Mini Rev Med Chem. 2021;21(7):816-832. doi: 10.2174/1389557520666201118153242. Mini Rev Med Chem. 2021. PMID: 33213355 Review.
Iron Complexes of Flavonoids-Antioxidant Capacity and Beyond.
Kejík Z, Kaplánek R, Masařík M, Babula P, Matkowski A, Filipenský P, Veselá K, Gburek J, Sýkora D, Martásek P, Jakubek M. Kejík Z, et al. Among authors: masarik m. Int J Mol Sci. 2021 Jan 11;22(2):646. doi: 10.3390/ijms22020646. Int J Mol Sci. 2021. PMID: 33440733 Free PMC article. Review.
Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design.
Kejík Z, Kaplánek R, Dytrych P, Masařík M, Veselá K, Abramenko N, Hoskovec D, Vašáková M, Králová J, Martásek P, Jakubek M. Kejík Z, et al. Among authors: masarik m. Pharmaceutics. 2021 Nov 5;13(11):1879. doi: 10.3390/pharmaceutics13111879. Pharmaceutics. 2021. PMID: 34834295 Free PMC article. Review.
Non-psychotropic cannabinoids as inhibitors of TET1 protein.
Antonyová V, Kejík Z, Brogyanyi T, Kaplánek R, Veselá K, Abramenko N, Ocelka T, Masařík M, Matkowski A, Gburek J, Abel R, Goede A, Preissner R, Novotný P, Jakubek M. Antonyová V, et al. Among authors: masarik m. Bioorg Chem. 2022 Jul;124:105793. doi: 10.1016/j.bioorg.2022.105793. Epub 2022 Apr 6. Bioorg Chem. 2022. PMID: 35462234
Pentamethinium salts suppress key metastatic processes by regulating mitochondrial function and inhibiting dihydroorotate dehydrogenase respiration.
Fialova JL, Hönigova K, Raudenska M, Miksatkova L, Zobalova R, Navratil J, Šmigová J, Moturu TR, Vicar T, Balvan J, Vesela K, Abramenko N, Kejik Z, Kaplanek R, Gumulec J, Rosel D, Martasek P, Brábek J, Jakubek M, Neuzil J, Masarik M. Fialova JL, et al. Among authors: masarik m. Biomed Pharmacother. 2022 Oct;154:113582. doi: 10.1016/j.biopha.2022.113582. Epub 2022 Aug 30. Biomed Pharmacother. 2022. PMID: 36055111 Free article.
Engine shutdown: migrastatic strategies and prevention of metastases.
Raudenská M, Petrláková K, Juriňáková T, Leischner Fialová J, Fojtů M, Jakubek M, Rösel D, Brábek J, Masařík M. Raudenská M, et al. Among authors: masarik m. Trends Cancer. 2023 Apr;9(4):293-308. doi: 10.1016/j.trecan.2023.01.001. Epub 2023 Feb 15. Trends Cancer. 2023. PMID: 36804341 Free article. Review.
TET protein inhibitors: Potential and limitations.
Kaplánek R, Kejík Z, Hajduch J, Veselá K, Kučnirová K, Skaličková M, Venhauerová A, Hosnedlová B, Hromádka R, Dytrych P, Novotný P, Abramenko N, Antonyová V, Hoskovec D, Babula P, Masařík M, Martásek P, Jakubek M. Kaplánek R, et al. Among authors: masarik m. Biomed Pharmacother. 2023 Oct;166:115324. doi: 10.1016/j.biopha.2023.115324. Epub 2023 Aug 18. Biomed Pharmacother. 2023. PMID: 37598475 Free article. Review.
133 results